| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Tennant Stanley serves as a Director at CRDF. Across recent SEC filings that breaks down to 4 buys and 1 sell. Those positions are worth an estimated $248K at current prices.
The biggest single holding is CRDF (~$248K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 36,632 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2018 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $0.80 | $8,000.00 | +4.4% | |
| Sep 5, 2017 | CRDF Cardiff Oncology, Inc. | Director | Sell | 8,334 | $0.69 | $5,750.46 | -3.8% | |
| Dec 19, 2016 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $2.10 | $21,000.00 | +4.8% | |
| Dec 16, 2016 | CRDF Cardiff Oncology, Inc. | Director | Buy | 14,966 | $2.00 | $29,932.00 | +7.8% | |
| Aug 12, 2015 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $6.06 | $60,600.00 | +5.5% |